Trial Profile
A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2018
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 09 Aug 2010 New trial record